Content about Peyton Howell

October 4, 2013

AmerisourceBergen on Friday announced the company will hold its annual manufacturer summit, ThinkLive 2013, Oct. 7 to 8 at the Fairmont Hotel in Dallas.

VALLEY FORGE, Pa. — AmerisourceBergen on Friday announced the company will hold its annual manufacturer summit, ThinkLive 2013, Oct. 7 to 8 at the Fairmont Hotel in Dallas. The trade show is expected to draw a diverse group of manufacturer executives from the pharmaceutical industry, including those responsible for pharmaceutical brand management, trade relations, supply chain, market access, reimbursement strategy, global pharmaceuticals, medical devices, over-the-counter products and global pharmaceuticals. 

March 4, 2013

The Center for Healthcare Supply Chain Research, the foundation of the Healthcare Distribution Management Association, announced the appointment of three directors to its board: including Gregory Drew, president of Value Drug; Peyton Howell, president of global sourcing and manufacturer relations at AmerisourceBergen; and, Kirk Kaminsky, SVP operations of McKesson Specialty Health.

ARLINGTON, Va. — The Center for Healthcare Supply Chain Research, the foundation of the Healthcare Distribution Management Association, on Friday announced the appointment of three directors to its board: including Gregory Drew, president of Value Drug Company; Peyton Howell, president of global sourcing and manufacturer relations at AmerisourceBergen; and, Kirk Kaminsky, SVP operations of McKesson Specialty Health.

December 5, 2012

Effective immediately, Peyton Howell named SVP AmerisourceBergen and president, global sourcing and manufacturer relations.

VALLEY FORGE, Pa. — AmerisourceBergen on Wednesday named Peyton Howell SVP AmerisourceBergen and president, global sourcing and manufacturer relations, effective immediately. 

September 21, 2012

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

PHILADELPHIA — The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said last week at the wholesaler's ThinkLive Manufacturer's Summit held here. "Next year is a slower brand-to-generic [trend] and in 2014 we’re going to see a resumption in that top-line growth rate [across the pharmaceutical industry in the U.S.] to a modest 4% growth," Collis said. "That’s not too bad," he added, especially when you compare that growth up against what's happening worldwide.